Annual report pursuant to Section 13 and 15(d)

REVENUES (Tables)

v3.19.3.a.u2
REVENUES (Tables)
12 Months Ended
Dec. 31, 2019
REVENUES  
Schedule of revenues disaggregated by category

Revenues disaggregated by category were as follows (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31,

 

 

 

2019

    

2018

    

2017

Product sales:

 

 

 

 

 

 

 

 

 

 

Gross product sales

 

 

$

53,082

 

$

16,953

 

$

 —

Discounts and allowances

 

 

 

(9,310)

 

 

(3,006)

 

 

 —

Product sales, net

 

 

$

43,772

 

$

13,947

 

$

 —

 

 

 

 

 

 

 

 

 

 

 

Revenues from collaborations:

 

 

 

 

 

 

 

 

 

 

License revenues

 

 

 

8,696

 

$

30,562

 

 

250

Development milestones

 

 

 

5,500

 

 

 —

 

 

4,234

Research and development services and others

 

 

 

1,320

 

 

 —

 

 

 —

Total revenues from collaborations

 

 

 

15,516

 

 

30,562

 

 

4,484

Total revenues

 

 

$

59,288

 

$

44,509

 

$

4,484

 

Customer revenues (as a percentage of gross revenues)

The following table summarizes revenues from each of our customers who individually accounted for 10% or more of our gross revenues (as a percentage of gross revenues):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31,

 

 

 

2019

    

2018

 

2017

ASD Healthcare and Oncology Supply

 

 

 

37%

 

 

17%

 

 

 —

McKesson Specialty Care Distribution Corporation

 

 

 

30%

 

 

11%

 

 

 —

Kissei

 

 

 

 —

 

 

69%

 

 

 —

BerGenBio

 

 

 

 —

 

 

 —

 

 

74%

 

Schedule of product revenue allowances and discounts

The following tables summarize activity in each of the product revenue allowances and discounts during the year ended December 31, 2019 (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Chargebacks,

 

Government

 

 

 

 

 

 

Discounts and

 

and Other

 

 

 

 

 

 

Fees

 

Rebates

 

Returns

 

Total

Balance at January 1, 2019

    

$

623

 

$

843

 

$

170

 

$

1,636

Provision related to current period sales

 

 

5,170

 

 

2,864

 

 

99

 

 

8,133

Credit or payments made during the period

 

 

(4,500)

 

 

(1,906)

 

 

(31)

 

 

(6,437)

Balance at December 31, 2019

 

$

1,293

 

$

1,801

 

$

238

 

$

3,332

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Chargebacks,

 

Government

 

 

 

 

 

 

 

 

Discounts and

 

and Other

 

 

 

 

 

 

 

 

Fees

 

Rebates

 

Returns

 

Total

Balance at January 1, 2018

    

$

 —

 

$

 —

 

$

 —

 

$

 —

Provision related to current period sales

 

 

1,484

 

 

1,068

 

 

170

 

 

2,722

Credit or payments made during the period

 

 

(861)

 

 

(225)

 

 

 —

 

 

(1,086)

Balance at December 31, 2018

 

$

623

 

$

843

 

$

170

 

$

1,636